Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Noel C et al. - Among high-immunological-risk renal transplant recipients, Thymoglobulin is superior to daclizumab for the prevention of biopsy-proven acute rejection, but there is no significant benefit to one-year graft or patient survival.

Today in Surgery/Transplantation...keeping you current

Indices of systemic atherosclerosis are superior to ultrasound resistance indices for prediction of allograft survival
Nephrology Dialysis Transplantation, 12/04/09

Therapy with Nonglycosaminoglycan-Binding Mutant CCL7: A Novel Strategy to Limit Allograft Inflammation
American Journal of Transplantation, 12/03/09

Intact LFA-1 deactivation promotes T-cell activation and rejection of cardiac allograft
International Immunology, 12/02/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address